A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
Association between colorectal cancer testing and insurance type: evidence from the Swiss Health Interview Survey 2012
2020
Preventive medicine reports
Both colonoscopy and fecal occult blood test (FOBT) are commonly used for colorectal cancer (CRC) screening, but colonoscopy costs much more than FOBT. Swiss insurance offers high or low deductibles and choice of basic or private insurance. We hypothesized that high deductibles and basic insurance discourage colonoscopy, but do not change FOBT rates. We determined the proportion of patients tested for CRC in Switzerland (colonoscopy within 10 years, FOBT within 2 years), and determined
doi:10.1016/j.pmedr.2020.101111
pmid:32426215
pmcid:PMC7226870
fatcat:ptplunax7fhftex3sva4l4rzh4